Inflammatory Molecule, PSGL-1, Deficiency Activates Macrophages to Promote Colorectal Cancer Growth Through NF-kappaB Signaling

Jiangchao Li,Zeqi Zhou,Xiaohan Zhang,Li Zheng,Dan He,Yuxiang Ye,Qianqian Zhang,Cuiling Qi,Xiaodong He,Chen Yu,Chunkui Shao,Liang Qiao,Lijing Wang
DOI: https://doi.org/10.1158/1541-7786.MCR-16-0309
2017-01-01
Molecular Cancer Research
Abstract:P-selectin glycoprotein ligand 1 (SELPLG/PSGL-1) is an inflammatory molecule that is functionally related to immune cell differentiation and leukocyte mobilization. However, the role of PSGL-1 in tumor development remains unknown. Therefore, this study investigates the mechanistic role of PSGL-1 in the development of intestinal tumors in colorectal cancer. Apc(Min/+) mice are highly susceptible to spontaneous intestinal adenoma formation, and were crossbred with PSGL1-null mice to generate compound transgenic mice with a Apc(Min/+); PSGL-1(-/)-genotype. The incidence and pathologic features of the intestinal tumors were compared between the Apc(Min/+) mice and Apc(Min/+); PSGL-1(-/)-mice. Importantly, PSGL-1-deficient mice showed increased susceptibility to develop intestinal tumors and accelerated tumor growth. Mechanistically, increased production of the mouse chemokine ligand 9 (CCL9/MIP-1 gamma) was found in the PSGL-1-deficient mice, and the macrophages are likely the major source of macrophage inflammatory protein-1 gamma (MIP-1 gamma). Studies in vitro demonstrated that macrophage-derived MIP-1g promoted colorectal cancer tumor cell growth through activating NF kappa B signaling. Conversely, restoration of the PSGL-1 signaling via bone marrow transplantation reduced MIP-1g production and attenuated the ability of Apc(Min/+); PSGL-1(-/)-mice to generate intestinal tumors. In human colorectal cancer clinical specimens, the presence of PSGL-1-positive cells was associated with a favorable tumornode-metastasis staging and decreased lymph node metastasis. Implications: PSGL-1 deficiency and inflammation render intestinal tissue more vulnerable to develop colorectal tumors through a MIP-1g/NF kappa B signaling axis. (C) 2017 AACR.
What problem does this paper attempt to address?